Correlation Between Connect Biopharma and SIGA Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and SIGA Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and SIGA Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Connect Biopharma Holdings and SIGA Technologies, you can compare the effects of market volatilities on Connect Biopharma and SIGA Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of SIGA Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and SIGA Technologies.

Diversification Opportunities for Connect Biopharma and SIGA Technologies

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Connect and SIGA is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and SIGA Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIGA Technologies and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with SIGA Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIGA Technologies has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and SIGA Technologies go up and down completely randomly.

Pair Corralation between Connect Biopharma and SIGA Technologies

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to under-perform the SIGA Technologies. In addition to that, Connect Biopharma is 1.26 times more volatile than SIGA Technologies. It trades about -0.04 of its total potential returns per unit of risk. SIGA Technologies is currently generating about 0.0 per unit of volatility. If you would invest  772.00  in SIGA Technologies on September 3, 2024 and sell it today you would lose (44.00) from holding SIGA Technologies or give up 5.7% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Connect Biopharma Holdings  vs.  SIGA Technologies

 Performance 
       Timeline  
Connect Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
SIGA Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SIGA Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, SIGA Technologies is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Connect Biopharma and SIGA Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Connect Biopharma and SIGA Technologies

The main advantage of trading using opposite Connect Biopharma and SIGA Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, SIGA Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIGA Technologies will offset losses from the drop in SIGA Technologies' long position.
The idea behind Connect Biopharma Holdings and SIGA Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bonds Directory
Find actively traded corporate debentures issued by US companies
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios